← Back to contracts

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas

US National Cancer Institute grant open #nih-5R01CA182076-08

Summary

PROJECT SUMMARY/ABSTRACT: Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are cystic tumors that represent a radiographically identifiable precursor lesion of pancreatic cancer. Currently, IPMN represent our best opportunity for intervention - and interception - prior to the development of an incurable cancer. The challenge however, is current laboratory, endoscopic, and imaging technologies are unable to distinguish between IPMN that is at low-risk (low-grade dysplasia) or at high-risk (high-grade dysplasia) of becoming an invasive cancer. In addition, our ability to improve d

Biomarker validation for intraductal papil…
Onboard